Latest news
Loading news…
Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.
Imago BioSciences was acquired by Merck in 2022 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
30
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Carlos, California, United States
Key People at Imago BioSciences
Director, Analytical Chemistry
Founder and CEO
Chief Operating Officer and Chief Business Officer
30
professional contacts at Imago BioSciences
Contact execs at Imago BioSciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Imago BioSciences
Loading news…
FAQs about Imago BioSciences
People who checked this page also checked these
Browse the full Acquirezy directory.